Format

Send to

Choose Destination
Aliment Pharmacol Ther. 2019 Apr;49(8):1088-1089. doi: 10.1111/apt.15200.

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.

Author information

1
Department of Medicine, University of Alberta, Edmonton, AB, Canada.
2
Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada.
3
Department of Gastroenterology, Catholic University of Leuven, Leuven, Belgium.
4
Department of Medicine, Farncombe Family Digestive Research Institute, McMaster University, Hamilton, ON, Canada.
5
Gastrointestinal Diseases Research Unit, Queen's University, Kingston, ON, Canada.
6
Department of Computing Science, University of Alberta, Edmonton, AB, Canada.
PMID:
30920043
DOI:
10.1111/apt.15200

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center